Lonafarnib-Based Regimens Look Promising for Patients With Chronic HDV Infection By Brian Park, PharmD Publish Date December 8, 2022
Dexcom G7 Continuous Glucose Monitoring System Gets FDA Clearance By Brian Park, PharmD Publish Date December 8, 2022
Bivalent COVID-19 Vaccines Authorized for Children 6 Months and Older By Brian Park, PharmD Publish Date December 8, 2022
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients Publish Date December 8, 2022
Adding Everolimus to Adjuvant ET Does Not Improve Survival in High-Risk HR+/HER2- Breast Cancer By Lauren Dembeck, PhD Publish Date December 7, 2022
Investigational Therapy Gets Fast Track Status for Glioblastoma Multiforme By Steve Duffy Brian Park, PharmD Publish Date December 7, 2022
Bivalent RSV Vaccine Candidate Gets Priority Review for Older Adults By Brian Park, PharmD Publish Date December 7, 2022
Empagliflozin Significantly Reduces HbA1c in Children With Type 2 Diabetes By Brian Park, PharmD Publish Date December 7, 2022
DFS Improved With AIs vs Tamoxifen in HR+, HER2- Early Breast Cancer By Jessica Nye, PhD Publish Date December 7, 2022
Investigating Racial Disparities in HR+, HER2- Breast Cancer By Andrea S. Blevins Primeau, PhD, MBA Publish Date December 7, 2022
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation Publish Date December 7, 2022
Narcan Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose By Brian Park, PharmD Publish Date December 6, 2022
Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status By Brian Park, PharmD Publish Date December 6, 2022
Delgocitinib Cream Significantly Improves Chronic Hand Eczema in Trial By Diana Ernst, RPh Publish Date December 6, 2022
